Autres langues Roche Holding AG Swiss Exchange

Actions

ROG

CH0012032048

Produits pharmaceutiques

Marché Fermé - Swiss Exchange Autres places de cotation 17:30:36 15/05/2026			Varia. 5j.	Varia. 1 janv.
322,80 ^CHF	+0,88%		+2,38%	-1,65%

15/05	La FDA approuve le Tecentriq de Genentech dans le traitement adjuvant du cancer de la vessie avec envahissement musculaire guidé par l'ADNtc	RE
15/05	Roche: feu vert de la FDA pour Tecentriq contre le cancer de la vessie	AW

Autres langues

15/05	Fda approves Genentech's Tecentriq for adjuvant muscle-invasive bladder cancer with ctDNA-guided treatment
15/05	Roche-Medikament Tecentriq erhält US-Zulassung bei Blasenkrebs
15/05	FDA approves atezolizumab for adjuvant treatment of muscle invasive bladder cancer in some patients
15/05	FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
15/05	Baillie Gifford European repositions portfolio as asset value falls
14/05	Roche-Mittel Gazyva soll in Japan für zusätzliche Indikation zugelassen werden
13/05	US FDA approves BeOne's drug for a type of blood cancer
12/05	Roche: "puntiamo con decisione sull'IA per favorire la diagnostica"
12/05	Roche Receives CE Mark For Elecsys Ptau217 Blood Test For Alzheimer?S Disease Pathology
12/05	Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030
12/05	Brüssel gibt grünes Licht für Alzheimer-Bluttest von Roche
12/05	Roche receives CE mark for new blood test to detect Alzheimer's pathology
12/05	Roche's Plasma Blood Test Secures CE Mark for Alzheimer's Pathology Detection
12/05	Roche mit Zulassung für einfachen Bluttest zur Alzheimer-Früherkennung
12/05	Roche gets second European approval for Alzheimer's test
07/05	Swiss Blue-chip Index Slips Amid Earnings Rush; Swiss Re Shares Down
07/05	Aktien Schweiz nach Vortagesrally deutlich im Minus
07/05	The Rally Spreads
07/05	Deals of the day-Mergers and acquisitions
07/05	Aktien Schweiz: Wenig verändert - gebremst von Swiss Re
07/05	European Midday Briefing : Stocks Gain in Cautious Trade Amidst Hope for Iran Peace
07/05	Roche acquisisce americana PathAI
07/05	Roche Holding AG entered into a definitive merger agreement to acquire PathAI, Inc. for $1.1 billion.
07/05	Morning Meeting: Los mercados vuelven a creer en Oriente Próximo
07/05	Morning Meeting: Die Erholung greift um sich